Advaxis Announces Agreement with Columbia University Irving Medical Center to Fund Phase 1 Study of ADXS-504 for the Treatment of Early Prostate Cancer

Ads

You May Also Like

Calithera Biosciences Appoints Blake Wise to Board of Directors

SOUTH SAN FRANCISCO, Calif., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), ...

BioSig Technologies, Inc. Achieves Important Milestone

Minneapolis, MN, Aug. 11, 2016 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device ...